ACCEL-AMPLICON™ PLUS LUNG CANCER PANEL

One powerful tool to screen genes implicated in NSCLC and SCLC.

The Accel-Amplicon Plus Lung Cancer Panel takes variant discovery and screening to a whole new level. It combines content from peer reviewed publications and other sources to offer comprehensive and exon-level hotspot coverage of 17 clinically-relevant lung genes for both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). But that’s just the beginning.

The panel is modular, allowing you to add focused content to achieve your most optimal design. Either choose from our pre-validated content or add your own targets. We’ll work alongside you to design your assay and then Swift will optimize and wet-bench validate its performance before shipping it to you.

Now you have a more powerful tool to facilitate your lung cancer sequencing.